BioCardia (BCDA) Common Equity (2009 - 2026)
BioCardia's Common Equity was $2.7 million in Q2 2026, compared with -$1.89 million a year earlier.
Analysis
BioCardia (BCDA) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at BioCardia came in at $895,000, up 6.9% from FY2024.
- Common Equity shows a five-year compound annual growth rate of -45.8% (FY2020 to FY2025).
- In earlier years, Common Equity was $837,000 in FY2024, -$1.6 million in FY2023, $4.89 million in FY2022 (-52.8%) and $10.38 million in FY2021 (-45.9%).
- The Q2 2026 figure marks the highest quarterly Common Equity since Q3 2024.
- The best year-over-year quarter for Common Equity over five years was Q3 2021 (growth of 226.1%); the worst was Q2 2023 (a decline of 75.7%).
- Per Business Quant data, BCDA's Common Equity in the three quarters before Q2 2026 was -$1.07 million (Q1 2026), $895,000 (Q4 2025) and $2.63 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | BioCardia | 11.25 Mn | -1.62 Mn | - | 2.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.70 Mn |
| Mar 31, 2026 | -1.07 Mn |
| Dec 31, 2025 | 895,000.00 |
| Sep 30, 2025 | 2.63 Mn |
| Jun 30, 2025 | -1.89 Mn |
| Mar 31, 2025 | -1.52 Mn |
| Dec 31, 2024 | 837,000.00 |
| Sep 30, 2024 | 2.75 Mn |
| Jun 30, 2024 | -1.96 Mn |
| Mar 31, 2024 | -2.28 Mn |
| Dec 31, 2023 | -1.60 Mn |
| Sep 30, 2023 | -660,000.00 |
| Jun 30, 2023 | 1.64 Mn |
| Mar 31, 2023 | 1.90 Mn |
| Dec 31, 2022 | 4.89 Mn |
| Sep 30, 2022 | 4.10 Mn |
| Jun 30, 2022 | 6.73 Mn |
| Mar 31, 2022 | 7.37 Mn |
| Dec 31, 2021 | 10.38 Mn |
| Sep 30, 2021 | 13.41 Mn |
API Access
BioCardia Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=BCDA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "BCDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=BCDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();